AI Article Synopsis

  • The paper discusses the synthesis of metallomesogens, which are materials that combine metal complexes with liquid crystals, specifically focusing on platinum(II) complexes.
  • It highlights the luminescent properties of these complexes, emphasizing how their unique structure affects their emission characteristics.
  • The study also investigates the polarized emission of the metallomesogens, showcasing their potential applications in advanced materials and optoelectronics.

Article Abstract

Correction for 'Metallomesogens based on platinum(II) complexes: synthesis, luminescence and polarized emission' by Yafei Wang , , 2011, , 5046-5051, https://doi.org/10.1039/C0DT01515F.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d4dt90181aDOI Listing

Publication Analysis

Top Keywords

based platinumii
8
platinumii complexes
8
complexes synthesis
8
synthesis luminescence
8
luminescence polarized
8
correction metallomesogens
4
metallomesogens based
4
polarized emission
4
emission correction
4
correction 'metallomesogens
4

Similar Publications

What happened to BBR3464 and where to from here for multinuclear platinum-based anticancer drugs?

Dalton Trans

December 2024

School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, NSW, 2109, Australia.

The development of the trinuclear platinum(II) complex BBR3464 (also known as triplatin) in the late 1990s was meant to be a revolution in the field of platinum chemotherapy. What made it remarkable was that it defied many of the known structure-activity rules for platinums; it is cationic, has a single labile leaving group on each terminal platinum, and it binds DNA in ways different to mononuclear platinum drugs, like cisplatin and oxaliplatin. The flexible, long-range adducts the drug forms with DNA means that it showed activity in cancers not typically sensitive to platinums, and more importantly, BBR3464 demonstrated an ability to overcome acquired resistance to platinum drugs.

View Article and Find Full Text PDF
Article Synopsis
  • - G-quadruplexes are important for cancer therapy, and understanding how compounds (ligands) interact with them is key for developing new anticancer drugs.
  • - A new platinum(II) complex (Pt1) was created using a berberine derivative as a ligand, and its structure was studied using various scientific methods.
  • - The study found that Pt1 binds well to G-quadruplex DNA, especially targeting the bcl-2 G-quadruplex, and showed effectiveness in inhibiting the growth of different tumor cells, indicating its potential as an antitumor agent.
View Article and Find Full Text PDF
Article Synopsis
  • The paper discusses the synthesis of metallomesogens, which are materials that combine metal complexes with liquid crystals, specifically focusing on platinum(II) complexes.
  • It highlights the luminescent properties of these complexes, emphasizing how their unique structure affects their emission characteristics.
  • The study also investigates the polarized emission of the metallomesogens, showcasing their potential applications in advanced materials and optoelectronics.
View Article and Find Full Text PDF

Synthesis of novel pyrimidine-based Schiff base complexes: Targeting Amyloid-β aggregation in Alzheimer's disease.

Bioorg Chem

November 2024

Department of Chemistry, Faculty of Science, Ege University, Bornova, Izmir 35100, Turkey. Electronic address:

Article Synopsis
  • A novel Schiff base compound, 5-((3,3-diphenylalilidene)amino)pyrimidine-4-amine (L), was synthesized along with new platinum and ruthenium complexes, which were characterized through various analytical techniques.
  • * The complexes demonstrated a strong ability to inhibit amyloid beta (Aβ) aggregation in human neuroblastoma cells (SH-SY5Y), significantly improving cell viability by up to 80% at 10 μM concentration compared to Aβ aggregation alone.
  • * Further investigations using advanced microscopy and spectroscopy techniques confirmed that these metal complexes actively engage with Aβ and effectively inhibit its aggregation.
View Article and Find Full Text PDF

Monoanionic and neutral nickel(II) and platinum(II) bis(dithiolene) complexes based on the 5,6-diethyl-5,6-dihydro-1,4-dithiin-2,3-dithiolate (de-dddt) chiral ligand have been prepared in racemic and enantiopure forms. Neutral closed-shell species have been generated from monoanionic precursors upon electrocrystallization. The racemic anionic (TBA)[Ni(,-de-dddt)(,-de-dddt)] complex crystallized in the centrosymmetric space group 2/, while the neutral complexes crystallized in the enantiomorphic tetragonal space group 422 or 422.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!